The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

S Singh, A Numan, B Maddiboyina, S Arora, Y Riadi… - Drug discovery today, 2021 - Elsevier
Highlights•TNBCs is one of the most heterogenous form of breast cancer appear to have
elevated numbers of immune cells infiltration.•Using immune checkpoint inhibitors (ICIs) …
被引用次数：79 相关文章

The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.

S Singh, A Numan, B Maddiboyina, S Arora… - Drug Discovery …, 2021 - europepmc.org
Triple-negative breast cancers (TNBCs) form a heterogeneous group of breast carcinomas
that lack expression of estrogen receptor, progesterone receptor and epidermal growth …

The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

S Singh, A Numan, B Maddiboyina… - Drug discovery …, 2021 - pubmed.ncbi.nlm.nih.gov
Triple-negative breast cancers (TNBCs) form a heterogeneous group of breast carcinomas
that lack expression of estrogen receptor, progesterone receptor and epidermal growth …